Paul J Tuite

M.D.

1990 …2021

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

  • mri

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies

Johnson, P. H., Weinreb, N. J., Cloyd, J. C., Tuite, P. J. & Kartha, R. V., Feb 2020, In : Molecular Genetics and Metabolism. 129, 2, p. 35-46 12 p.

Research output: Contribution to journalReview article

  • McLeod syndrome: Five new pedigrees with novel mutations

    Weaver, J., Sarva, H., Barone, D., Bobker, S., Bushara, K., Hiller, A., Ishii, M., Jankovic, J., Lakhani, S., Niotis, K., Scharre, D. W., Tuite, P., Stutz, A., Westhoff, C. M. & Walker, R. H., Jul 2019, In : Parkinsonism and Related Disorders. 64, p. 293-299 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Motor phenotype classification in moderate to advanced PD in BioFIND study

    Luo, L., Andrews, H., Alcalay, R. N., Poyraz, F. C., Boehme, A. K., Goldman, J. G., Xie, T., Tuite, P., Henchcliffe, C., Hogarth, P., Amara, A. W., Frank, S., Sutherland, M., Kopil, C., Naito, A. & Kang, U. J., Aug 2019, In : Parkinsonism and Related Disorders. 65, p. 178-183 6 p.

    Research output: Contribution to journalArticle

  • Neurochemical abnormalities in patients with type 1 Gaucher disease on standard of care therapy

    Kartha, R. V., Joers, J., Terluk, M. R., Travis, A., Rudser, K., Tuite, P. J., Weinreb, N. J., Jarnes, J. R., Cloyd, J. C. & Öz, G., Jan 1 2019, (Accepted/In press) In : Journal of Inherited Metabolic Disease.

    Research output: Contribution to journalArticle

  • Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial

    Boxer, A. L., Qureshi, I., Ahlijanian, M., Grundman, M., Golbe, L. I., Litvan, I., Honig, L. S., Tuite, P., McFarland, N. R., O'Suilleabhain, P., Xie, T., Tirucherai, G. S., Bechtold, C., Bordelon, Y., Geldmacher, D. S., Grossman, M., Isaacson, S., Zesiewicz, T., Olsson, T., Muralidharan, K. K. & 4 others, Graham, D. L., O'Gorman, J., Haeberlein, S. B. & Dam, T., Jun 2019, In : The Lancet Neurology. 18, 6, p. 549-558 10 p.

    Research output: Contribution to journalArticle

  • 12 Scopus citations